Wolff-Parkinson-White syndrome risk stratification: Difference between revisions

Jump to navigation Jump to search
Sara Zand (talk | contribs)
Sara Zand (talk | contribs)
Line 10: Line 10:
*Abrupt loss of conduction over the pathway during [[ exercise test]] in [[sinus rhythm]]
*Abrupt loss of conduction over the pathway during [[ exercise test]] in [[sinus rhythm]]
*Intermittent loss of preexcitation during [[EKG]] or [[ambulatory monitoring]]
*Intermittent loss of preexcitation during [[EKG]] or [[ambulatory monitoring]]
:*High-risk patients for life-threatening arrhythmia in the [[electrophysiologic study]] include the following:
:*High-risk patients for life-threatening arrhythmia in the [[electrophysiologic study]] include the following:


Line 15: Line 16:
* The presence of multiple [[accessory pathways]]
* The presence of multiple [[accessory pathways]]
* The finding of [[AVRT]] precipitating pre-excited [[AF]]
* The finding of [[AVRT]] precipitating pre-excited [[AF]]
ofabruptlossofconductionoverthe
pathway duringexercisetestinginsinusrhythm294–297 (Level ofEvidence:B-NR) or intermittentloss
of pre-excitationduringECGorambulatorymonitoring297 (Level ofEvidence:C-LD) are usefulfor
identifying patientsatlowriskofdevelopingrapidconductionoverthepathway
areanR-Rinterval o250 msbetween2pre-excitedcomplexes
during inducedAF;thepresenceofmultipleaccessorypathways;the finding ofAVRTprecipitating
pre-excited AF;andanaccessorypathwayrefractoryperiod o240 ms


==References==
==References==

Revision as of 09:10, 15 September 2020

Wolff-Parkinson-White syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Differentiating Wolff-Parkinson-White syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Approach

History and Symptoms

Electrocardiogram

EKG Examples

Other Diagnostic Studies

Treatment

Risk Stratification

Cardioversion

Medical Therapy

Catheter Ablation

Prophylaxis

Consensus Statement

Case Studies

Case #1

Wolff-Parkinson-White syndrome risk stratification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Wolff-Parkinson-White syndrome risk stratification

CDC onWolff-Parkinson-White syndrome risk stratification

Wolff-Parkinson-White syndrome risk stratification in the news

Blogs on Wolff-Parkinson-White syndrome risk stratification

Directions to Hospitals Treating Deep vein thrombosis

Risk calculators and risk factors for Wolff-Parkinson-White syndrome risk stratification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Cafer Zorkun, M.D., Ph.D. [2]

Overview

Treatment is based on risk stratification of the individual. Risk stratification is performed to determine which individuals with WPW syndrome are at risk for sudden cardiac death (SCD). Sudden cardiac death in these individuals is due to the propagation of an atrial arrhythmia to the ventricles at a very high rate.

Risk Stratification

  • Low-risk patients for life-threatening arrhythmia over the accessory pathway during AF include the following:
  • R-R<250 ms between two pre-excited complexes during induced AF
  • The presence of multiple accessory pathways
  • The finding of AVRT precipitating pre-excited AF

References

Template:WH Template:WS